HEADER VIRAL PROTEIN 06-DEC-10 3PUN TITLE CRYSTAL STRUCTURE OF P DOMAIN DIMER OF NOROVIRUS VA207 WITH LEWIS Y TITLE 2 TETRASACCHARIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAPSID; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: P DOMAIN, UNP RESIDUES 222-537; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN CALICIVIRUS; SOURCE 3 ORGANISM_TAXID: 165510; SOURCE 4 STRAIN: VA97207; SOURCE 5 GENE: CAPSID; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1 KEYWDS GREEK KEY, MIXED ALPHA/BETA STRUCTURE, RECEPTOR BINDING, KEYWDS 2 CARBOHYDRATE/SUGAR BINDING, CAPSID, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.CHEN,M.TAN,M.XIA,N.HAO,X.C.ZHANG,P.HUANG,X.JIANG,X.LI,Z.RAO REVDAT 5 01-NOV-23 3PUN 1 HETSYN REVDAT 4 29-JUL-20 3PUN 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 08-NOV-17 3PUN 1 REMARK REVDAT 2 11-APR-12 3PUN 1 JRNL REVDAT 1 03-AUG-11 3PUN 0 JRNL AUTH Y.CHEN,M.TAN,M.XIA,N.HAO,X.C.ZHANG,P.HUANG,X.JIANG,X.LI, JRNL AUTH 2 Z.RAO JRNL TITL CRYSTALLOGRAPHY OF A LEWIS-BINDING NOROVIRUS, ELUCIDATION OF JRNL TITL 2 STRAIN-SPECIFICITY TO THE POLYMORPHIC HUMAN HISTO-BLOOD JRNL TITL 3 GROUP ANTIGENS JRNL REF PLOS PATHOG. V. 7 02152 2011 JRNL REFN ISSN 1553-7366 JRNL PMID 21811409 JRNL DOI 10.1371/JOURNAL.PPAT.1002152 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.100 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 40540 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2031 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 21.8069 - 5.0287 1.00 2849 157 0.1599 0.1700 REMARK 3 2 5.0287 - 3.9995 0.99 2694 162 0.1382 0.1468 REMARK 3 3 3.9995 - 3.4963 0.99 2678 149 0.1651 0.1757 REMARK 3 4 3.4963 - 3.1777 0.99 2670 131 0.1942 0.2313 REMARK 3 5 3.1777 - 2.9505 0.98 2624 156 0.2115 0.2377 REMARK 3 6 2.9505 - 2.7769 0.97 2579 146 0.2228 0.2342 REMARK 3 7 2.7769 - 2.6381 0.97 2606 115 0.2146 0.2654 REMARK 3 8 2.6381 - 2.5234 0.97 2565 144 0.2089 0.2248 REMARK 3 9 2.5234 - 2.4264 0.95 2513 126 0.2051 0.1987 REMARK 3 10 2.4264 - 2.3428 0.95 2545 104 0.1975 0.2641 REMARK 3 11 2.3428 - 2.2696 0.93 2489 125 0.1913 0.2469 REMARK 3 12 2.2696 - 2.2048 0.95 2506 139 0.2013 0.2203 REMARK 3 13 2.2048 - 2.1468 0.92 2438 116 0.2042 0.2399 REMARK 3 14 2.1468 - 2.0945 0.92 2411 127 0.2168 0.2590 REMARK 3 15 2.0945 - 2.0469 0.90 2342 134 0.2210 0.2526 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 32.70 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 1.580 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.20980 REMARK 3 B22 (A**2) : -5.97870 REMARK 3 B33 (A**2) : 7.36070 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4908 REMARK 3 ANGLE : 1.069 6698 REMARK 3 CHIRALITY : 0.249 740 REMARK 3 PLANARITY : 0.005 890 REMARK 3 DIHEDRAL : 16.755 1774 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PUN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000062832. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : RIGAKU OSMIC VARIMAX CONFOCAL REMARK 200 OPTICS REMARK 200 OPTICS : RIGAKU OSMIC VARIMAX CONFOCAL REMARK 200 OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42294 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.3.3 REMARK 200 STARTING MODEL: PDB ENTRY 3PUM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% (W/V) PEG 3350, 50MM MAGNESIUM REMARK 280 FORMATE, PH 7.3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.58400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.99050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.06150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.99050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.58400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.06150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 222 REMARK 465 LYS A 223 REMARK 465 THR A 224 REMARK 465 LYS A 225 REMARK 465 GLY A 528 REMARK 465 THR A 529 REMARK 465 GLY A 530 REMARK 465 SER A 531 REMARK 465 GLY A 532 REMARK 465 ARG A 533 REMARK 465 ARG A 534 REMARK 465 ARG A 535 REMARK 465 ILE A 536 REMARK 465 GLN A 537 REMARK 465 SER B 222 REMARK 465 LYS B 223 REMARK 465 THR B 224 REMARK 465 LYS B 225 REMARK 465 GLY B 528 REMARK 465 THR B 529 REMARK 465 GLY B 530 REMARK 465 SER B 531 REMARK 465 GLY B 532 REMARK 465 ARG B 533 REMARK 465 ARG B 534 REMARK 465 ARG B 535 REMARK 465 ILE B 536 REMARK 465 GLN B 537 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 260 57.63 -141.87 REMARK 500 PHE A 397 115.94 -34.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PUM RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT LEWIS Y TETRASACCHARIDE REMARK 900 RELATED ID: 3PVD RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 3'-SIALYL-LEWIS-X TETRASACCHARIDE DBREF 3PUN A 222 537 UNP Q91H09 Q91H09_9CALI 222 537 DBREF 3PUN B 222 537 UNP Q91H09 Q91H09_9CALI 222 537 SEQADV 3PUN ASN A 289 UNP Q91H09 THR 289 ENGINEERED MUTATION SEQADV 3PUN ASP A 374 UNP Q91H09 ASN 374 ENGINEERED MUTATION SEQADV 3PUN GLY A 425 UNP Q91H09 ARG 425 ENGINEERED MUTATION SEQADV 3PUN ARG A 466 UNP Q91H09 GLN 466 ENGINEERED MUTATION SEQADV 3PUN ALA A 482 UNP Q91H09 VAL 482 ENGINEERED MUTATION SEQADV 3PUN ASN B 289 UNP Q91H09 THR 289 ENGINEERED MUTATION SEQADV 3PUN ASP B 374 UNP Q91H09 ASN 374 ENGINEERED MUTATION SEQADV 3PUN GLY B 425 UNP Q91H09 ARG 425 ENGINEERED MUTATION SEQADV 3PUN ARG B 466 UNP Q91H09 GLN 466 ENGINEERED MUTATION SEQADV 3PUN ALA B 482 UNP Q91H09 VAL 482 ENGINEERED MUTATION SEQRES 1 A 316 SER LYS THR LYS ALA PHE THR ILE PRO VAL LEU LYS ILE SEQRES 2 A 316 SER GLU MET THR ASN SER ARG PHE PRO VAL PRO VAL ASP SEQRES 3 A 316 GLN MET TYR THR SER ARG SER GLU GLY ILE VAL VAL GLN SEQRES 4 A 316 PRO GLN ASN GLY ARG ALA THR ILE ASP GLY GLU LEU LEU SEQRES 5 A 316 GLY THR THR LEU VAL SER PRO VAL SER VAL CYS ASN PHE SEQRES 6 A 316 LYS GLY ASN LEU GLN ALA GLU VAL PRO GLY GLN HIS GLN SEQRES 7 A 316 LEU TYR GLN LEU GLN LEU THR ASN LEU ASP GLY SER PRO SEQRES 8 A 316 ILE ASP PRO THR ASP ASP THR PRO GLY PRO LEU GLY CYS SEQRES 9 A 316 PRO ASP PHE THR GLY LEU LEU TYR GLY VAL ALA SER GLN SEQRES 10 A 316 ARG GLY PRO GLY ASP ALA THR ARG ALA HIS GLU ALA ARG SEQRES 11 A 316 ILE ASP THR GLY SER ASP THR PHE ALA PRO LYS ILE GLY SEQRES 12 A 316 GLN VAL ARG PHE TYR SER THR SER SER ASP PHE GLU THR SEQRES 13 A 316 ASN GLN PRO THR HIS PHE THR PRO ILE GLY ILE TYR ILE SEQRES 14 A 316 GLU GLY ASN SER SER ASP PHE ASN GLN TRP GLN LEU PRO SEQRES 15 A 316 ARG TYR GLY GLY HIS LEU ALA ASN ASN ASN HIS LEU ALA SEQRES 16 A 316 PRO ALA VAL SER PRO LEU PHE PRO GLY GLU GLN ILE LEU SEQRES 17 A 316 PHE PHE ARG SER PHE ILE PRO GLY ALA SER GLY HIS THR SEQRES 18 A 316 ASN GLY GLU MET ASP CYS LEU LEU PRO GLN GLU PHE VAL SEQRES 19 A 316 GLN HIS PHE TYR GLN GLU ALA ALA THR ALA ARG SER GLU SEQRES 20 A 316 VAL ALA LEU LEU ARG PHE VAL ASN PRO ASP THR GLY ARG SEQRES 21 A 316 ALA LEU PHE GLU SER LYS LEU HIS LYS GLN GLY PHE MET SEQRES 22 A 316 THR ILE ALA SER SER GLY ASP HIS PRO ILE ILE MET PRO SEQRES 23 A 316 THR ASN GLY TYR PHE ARG PHE GLU ALA TRP VAL ASN GLN SEQRES 24 A 316 PHE TYR SER LEU ALA PRO VAL GLY THR GLY SER GLY ARG SEQRES 25 A 316 ARG ARG ILE GLN SEQRES 1 B 316 SER LYS THR LYS ALA PHE THR ILE PRO VAL LEU LYS ILE SEQRES 2 B 316 SER GLU MET THR ASN SER ARG PHE PRO VAL PRO VAL ASP SEQRES 3 B 316 GLN MET TYR THR SER ARG SER GLU GLY ILE VAL VAL GLN SEQRES 4 B 316 PRO GLN ASN GLY ARG ALA THR ILE ASP GLY GLU LEU LEU SEQRES 5 B 316 GLY THR THR LEU VAL SER PRO VAL SER VAL CYS ASN PHE SEQRES 6 B 316 LYS GLY ASN LEU GLN ALA GLU VAL PRO GLY GLN HIS GLN SEQRES 7 B 316 LEU TYR GLN LEU GLN LEU THR ASN LEU ASP GLY SER PRO SEQRES 8 B 316 ILE ASP PRO THR ASP ASP THR PRO GLY PRO LEU GLY CYS SEQRES 9 B 316 PRO ASP PHE THR GLY LEU LEU TYR GLY VAL ALA SER GLN SEQRES 10 B 316 ARG GLY PRO GLY ASP ALA THR ARG ALA HIS GLU ALA ARG SEQRES 11 B 316 ILE ASP THR GLY SER ASP THR PHE ALA PRO LYS ILE GLY SEQRES 12 B 316 GLN VAL ARG PHE TYR SER THR SER SER ASP PHE GLU THR SEQRES 13 B 316 ASN GLN PRO THR HIS PHE THR PRO ILE GLY ILE TYR ILE SEQRES 14 B 316 GLU GLY ASN SER SER ASP PHE ASN GLN TRP GLN LEU PRO SEQRES 15 B 316 ARG TYR GLY GLY HIS LEU ALA ASN ASN ASN HIS LEU ALA SEQRES 16 B 316 PRO ALA VAL SER PRO LEU PHE PRO GLY GLU GLN ILE LEU SEQRES 17 B 316 PHE PHE ARG SER PHE ILE PRO GLY ALA SER GLY HIS THR SEQRES 18 B 316 ASN GLY GLU MET ASP CYS LEU LEU PRO GLN GLU PHE VAL SEQRES 19 B 316 GLN HIS PHE TYR GLN GLU ALA ALA THR ALA ARG SER GLU SEQRES 20 B 316 VAL ALA LEU LEU ARG PHE VAL ASN PRO ASP THR GLY ARG SEQRES 21 B 316 ALA LEU PHE GLU SER LYS LEU HIS LYS GLN GLY PHE MET SEQRES 22 B 316 THR ILE ALA SER SER GLY ASP HIS PRO ILE ILE MET PRO SEQRES 23 B 316 THR ASN GLY TYR PHE ARG PHE GLU ALA TRP VAL ASN GLN SEQRES 24 B 316 PHE TYR SER LEU ALA PRO VAL GLY THR GLY SER GLY ARG SEQRES 25 B 316 ARG ARG ILE GLN HET NDG C 1 15 HET GAL C 2 11 HET FUC C 3 10 HET FUC C 4 10 HET NDG D 1 15 HET GAL D 2 11 HET FUC D 3 10 HET FUC D 4 10 HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NDG 2(C8 H15 N O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 3 FUC 4(C6 H12 O5) FORMUL 5 HOH *333(H2 O) HELIX 1 1 LYS A 233 MET A 237 5 5 HELIX 2 2 ALA A 360 ILE A 363 5 4 HELIX 3 3 PRO A 451 ALA A 462 1 12 HELIX 4 4 LYS B 233 MET B 237 5 5 HELIX 5 5 ALA B 360 ILE B 363 5 4 HELIX 6 6 PRO B 451 ALA B 462 1 12 SHEET 1 A 4 GLU A 445 CYS A 448 0 SHEET 2 A 4 GLU A 426 PHE A 434 -1 N PHE A 431 O CYS A 448 SHEET 3 A 4 GLN A 248 SER A 252 -1 N TYR A 250 O PHE A 430 SHEET 4 A 4 HIS A 502 ILE A 504 -1 O HIS A 502 N THR A 251 SHEET 1 B 6 GLU A 445 CYS A 448 0 SHEET 2 B 6 GLU A 426 PHE A 434 -1 N PHE A 431 O CYS A 448 SHEET 3 B 6 PHE A 493 ALA A 497 -1 O MET A 494 N LEU A 429 SHEET 4 B 6 ALA A 482 HIS A 489 -1 N HIS A 489 O PHE A 493 SHEET 5 B 6 VAL A 469 VAL A 475 -1 N PHE A 474 O LEU A 483 SHEET 6 B 6 TYR A 511 VAL A 518 -1 O ALA A 516 N LEU A 471 SHEET 1 C 8 GLY A 437 SER A 439 0 SHEET 2 C 8 PRO A 380 TYR A 389 1 N ILE A 388 O ALA A 438 SHEET 3 C 8 LEU A 331 ARG A 339 -1 N TYR A 333 O GLY A 387 SHEET 4 C 8 THR A 345 ASP A 353 -1 O ARG A 346 N GLN A 338 SHEET 5 C 8 GLN A 365 TYR A 369 -1 O TYR A 369 N ARG A 351 SHEET 6 C 8 LEU A 300 THR A 306 -1 N LEU A 303 O VAL A 366 SHEET 7 C 8 PHE A 286 GLU A 293 -1 N ALA A 292 O GLN A 302 SHEET 8 C 8 PRO A 380 TYR A 389 -1 O THR A 381 N GLY A 288 SHEET 1 D 4 GLU B 445 CYS B 448 0 SHEET 2 D 4 GLU B 426 PHE B 434 -1 N PHE B 431 O CYS B 448 SHEET 3 D 4 GLN B 248 THR B 251 -1 N TYR B 250 O PHE B 430 SHEET 4 D 4 HIS B 502 ILE B 504 -1 O ILE B 504 N MET B 249 SHEET 1 E 6 GLU B 445 CYS B 448 0 SHEET 2 E 6 GLU B 426 PHE B 434 -1 N PHE B 431 O CYS B 448 SHEET 3 E 6 PHE B 493 ALA B 497 -1 O MET B 494 N LEU B 429 SHEET 4 E 6 ALA B 482 HIS B 489 -1 N HIS B 489 O PHE B 493 SHEET 5 E 6 VAL B 469 VAL B 475 -1 N ALA B 470 O LEU B 488 SHEET 6 E 6 TYR B 511 VAL B 518 -1 O ALA B 516 N LEU B 471 SHEET 1 F 8 GLY B 437 SER B 439 0 SHEET 2 F 8 PRO B 380 TYR B 389 1 N ILE B 388 O ALA B 438 SHEET 3 F 8 LEU B 331 ARG B 339 -1 N SER B 337 O HIS B 382 SHEET 4 F 8 THR B 345 ASP B 353 -1 O ALA B 350 N GLY B 334 SHEET 5 F 8 GLN B 365 TYR B 369 -1 O TYR B 369 N ARG B 351 SHEET 6 F 8 LEU B 300 THR B 306 -1 N TYR B 301 O PHE B 368 SHEET 7 F 8 PHE B 286 GLU B 293 -1 N ALA B 292 O GLN B 302 SHEET 8 F 8 PRO B 380 TYR B 389 -1 O THR B 381 N GLY B 288 LINK O4 NDG C 1 C1 GAL C 2 1555 1555 1.42 LINK O3 NDG C 1 C1 FUC C 4 1555 1555 1.43 LINK O2 GAL C 2 C1 FUC C 3 1555 1555 1.44 LINK O4 NDG D 1 C1 GAL D 2 1555 1555 1.45 LINK O3 NDG D 1 C1 FUC D 4 1555 1555 1.38 LINK O2 GAL D 2 C1 FUC D 3 1555 1555 1.31 CISPEP 1 GLY A 340 PRO A 341 0 -1.69 CISPEP 2 GLY B 340 PRO B 341 0 -1.63 CRYST1 67.168 96.123 101.981 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014888 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009806 0.00000